Thus, treatment of severe or acute hyperglycemia secondary to cardiovascular diseases with a basal-bolus insulin regimen is reasonable, where the bolus doses are administered to control the excessive rise of postprandial blood glucose levels. Here, INS is linked to Hyperglycemia.